Bruna Neuberger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bruna Neuberger has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Fernanda Kulinski Mello
Graduate Program in Pharmacology, Federal University of Santa Maria, Santa Maria 97105-900, Brazil
2 shared publications - Karine Gabriela da Costa Sobral
Graduate Program in Pharmacology, Federal University of Santa Maria, Santa Maria 97105-900, Brazil
2 shared publications - Mauro Schneider Oliveira
Graduate Program in Pharmacology, Federal University of Santa Maria Santa Maria Brazil
2 shared publications - Michele Pereira Mallmann
Graduate Program in Pharmacology, Federal University of Santa Maria, Santa Maria 97105-900, Brazil
2 shared publications - Tuane Bazanella Sampaio
Universidade Estadual do Centro-Oeste
2 shared publications - Ana Flávia Furian
Centro de Ciências Rurais, Departamento de Tecnologia e Ciência dos Alimentos, Universidade Federal de Santa Maria, Santa Maria - RS, Brasil
1 shared publication
Latest Publications
- Open Access
- 8 February 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (2) , 289
Beneficial Effects of Rosmarinic Acid In Vitro and In Vivo Models of Epileptiform Activity Induced by Pilocarpine
Epilepsy is characterized by a predisposition to generate recurrent and spontaneous seizures; it affects millions of people worldwide. Status epilepticus (SE) is a severe type of seizure. In this context, screening potential treatments is very important. In the present study, we evaluated the beneficial effects of rosmarinic acid (RA) in pilocarpine-induced in vitro and in vivo models of epileptiform activity. Using an in vitro model in combined entorhinal cortex–hippocampal from Wistar rats we evaluated the effects of RA (10 µg/mL) on the lactate release and a glucose fluorescent analogue, 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NDBG), after incubation in high potassium aCSF supplemented or not with pilocarpine. In the in vivo model, SE was induced in male C57BL/6 mice by pilocarpine. At 1, 24, and 48 h after the end of SE mice were treated with RA (30 mg/kg/v.o.). We evaluated the neuromotor impairment by neuroscore tests and protein carbonyl levels in the cerebral cortex. In both in vitro models, RA was able to decrease the stimulated lactate release, while no effect on 2-NBDG uptake was found. RA has beneficial effects in models of epileptiform activity in vivo and in vitro. We found that RA treatment attenuated SE-induced neuromotor impairment at the 48 h timepoint. Moreover, post-SE treatment with RA decreased levels of protein carbonyls in the cerebral cortex of mice when compared to their vehicle-treated counterparts. Importantly, RA was effective in a model of SE which is relevant for the human condition. The present data add to the literature on the biological effects of RA, which could be a good candidate for add-on therapy in epilepsy.
- 8 February 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (2) , 289
Open AccessBeneficial Effects of Rosmarinic Acid In Vitro and In Vivo Models of Epileptiform Activity Induced by Pilocarpine
Epilepsy is characterized by a predisposition to generate recurrent and spontaneous seizures; it affects millions of people worldwide. Status epilepticus (SE) is a severe type of seizure. In this context, screening potential treatments is very important. In the present study, we evaluated the beneficial effects of rosmarinic acid (RA) in pilocarpine-induced in vitro and in vivo models of epileptiform activity. Using an in vitro model in combined entorhinal cortex–hippocampal from Wistar rats we evaluated the effects of RA (10 µg/mL) on the lactate release and a glucose fluorescent analogue, 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NDBG), after incubation in high potassium aCSF supplemented or not with pilocarpine. In the in vivo model, SE was induced in male C57BL/6 mice by pilocarpine. At 1, 24, and 48 h after the end of SE mice were treated with RA (30 mg/kg/v.o.). We evaluated the neuromotor impairment by neuroscore tests and protein carbonyl levels in the cerebral cortex. In both in vitro models, RA was able to decrease the stimulated lactate release, while no effect on 2-NBDG uptake was found. RA has beneficial effects in models of epileptiform activity in vivo and in vitro. We found that RA treatment attenuated SE-induced neuromotor impairment at the 48 h timepoint. Moreover, post-SE treatment with RA decreased levels of protein carbonyls in the cerebral cortex of mice when compared to their vehicle-treated counterparts. Importantly, RA was effective in a model of SE which is relevant for the human condition. The present data add to the literature on the biological effects of RA, which could be a good candidate for add-on therapy in epilepsy.
- 1 January 2022
- Published by Elsevier in Epilepsy Research
- Vol. 179, 106842
Anticonvulsant activity of β-caryophyllene in association with pregabalin in a seizure model in rats
- 1 January 2022
- Published by Elsevier in Epilepsy Research
- Vol. 179, 106842
Anticonvulsant activity of β-caryophyllene in association with pregabalin in a seizure model in rats